NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 03:24PM ET
1.40
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-198.87 Insider Own10.36% Shs Outstand2.01M Perf Week-3.45%
Market Cap2.82M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.80M Perf Month-30.69%
Enterprise Value0.09M PEG- EPS next Q- Inst Own0.03% Short Float5.21% Perf Quarter-39.13%
Income-17.67M P/S- EPS this Y- Inst Trans-41.96% Short Ratio0.07 Perf Half Y-56.25%
Sales0.00M P/B- EPS next Y- ROA-309.43% Short Interest0.09M Perf YTD-58.27%
Book/sh-14.12 P/C1.01 EPS next 5Y- ROE-716.67% 52W High16.63 -91.58% Perf Year-88.03%
Cash/sh1.39 P/FCF- EPS past 3/5Y43.38% 12.33% ROIC- 52W Low1.25 12.00% Perf 3Y-99.41%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility5.81% 6.39% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM9.41% Oper. Margin- ATR (14)0.11 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.61 Sales Y/Y TTM- Profit Margin- RSI (14)33.33 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.61 EPS Q/Q-3.64% SMA20-16.16% Beta0.56 Target Price48.00
Payout- Debt/Eq- Sales Q/Q- SMA50-26.77% Rel Volume0.01 Prev Close1.40
Employees6 LT Debt/Eq- Earnings- SMA200-47.20% Avg Volume1.40M Price1.40
IPOSep 01, 2020 Option/ShortNo / Yes EPS/Sales Surpr.-5.77% - Trades Volume14,291 Change0.00%
May-27-25 12:12PM
May-07-25 04:30PM
Apr-10-25 08:30AM
Apr-07-25 05:00PM
Mar-06-25 11:06AM
11:00AM Loading…
Mar-05-25 11:00AM
Feb-18-25 08:30AM
Dec-28-24 09:17AM
Dec-27-24 08:30AM
Nov-20-24 08:30AM
Nov-07-24 05:00PM
Oct-25-24 09:25AM
Sep-11-24 08:30AM
Sep-10-24 09:46AM
Sep-09-24 12:14PM
08:30AM Loading…
Aug-21-24 08:30AM
Aug-20-24 08:30AM
Aug-15-24 08:00AM
Aug-12-24 09:00AM
Aug-07-24 10:00AM
Aug-05-24 09:00AM
Aug-01-24 08:30AM
Jul-24-24 08:30AM
Jun-26-24 08:00AM
Jun-14-24 07:30AM
May-31-24 04:15PM
May-15-24 10:54PM
04:05PM
May-08-24 08:30AM
Apr-18-24 02:19PM
08:00AM Loading…
Apr-16-24 08:00AM
Apr-09-24 10:30AM
09:00AM
Apr-02-24 10:00AM
08:30AM
Mar-01-24 08:00AM
Jan-22-24 08:30AM
Jan-03-24 08:30AM
Dec-26-23 06:00PM
Nov-15-23 04:05PM
Sep-11-23 08:30AM
Sep-07-23 10:00AM
Sep-05-23 08:30AM
Aug-10-23 04:05PM
06:45AM
Jul-19-23 09:00AM
Jul-14-23 02:35PM
Jul-12-23 09:05AM
Jul-03-23 09:01AM
Jun-15-23 08:30AM
Jun-07-23 04:30PM
May-18-23 09:00AM
May-15-23 04:45PM
May-02-23 08:30AM
May-01-23 08:30AM
Apr-17-23 09:00AM
Mar-28-23 09:10AM
Mar-16-23 08:00AM
Mar-14-23 08:00AM
Feb-07-23 04:05PM
Nov-15-22 08:30AM
Nov-08-22 08:30AM
Oct-04-22 09:00AM
Sep-01-22 08:00AM
Aug-16-22 08:05AM
08:00AM
May-17-22 07:00AM
Apr-12-22 09:00AM
Mar-21-22 09:25AM
Mar-17-22 08:00AM
Dec-14-21 08:30AM
Nov-22-21 11:58AM
07:02AM
Nov-16-21 08:00AM
Oct-14-21 08:30AM
Aug-16-21 08:00AM
Jun-15-21 12:46PM
May-24-21 06:35AM
May-13-21 08:15AM
Mar-18-21 09:15AM
Mar-11-21 10:43AM
Mar-08-21 09:00AM
Jan-07-21 08:30AM
Jan-06-21 08:30AM
Jan-04-21 08:30AM
Nov-23-20 08:30AM
Nov-12-20 09:00AM
Nov-05-20 08:30AM
Oct-19-20 09:00AM
Sep-29-20 07:30AM
Sep-09-20 02:15PM
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.